GAC conducted two Strategic Portfolio Planning projects for a BioTech client in 2005 and 2010 and developed the strategic portfolio plan from four phases of work:
- Built a decision framework and clarified the potential disease area targets, then conducted a market landscape assessment across 32 potential target indications/disease areas.
- Used the framework to clarify the range of opportunities. Developed the characteristics of each opportunity and tested approximately 20 targets via primary research with physicians, molecular laboratorians, and thought leaders. Conducted more than 60 in-depth interviews and synthesized results to qualify and refine 11 of the targets.
- Built an economic forecasting model for each viable alternative. Model consisted of both epidemiology-based and market size-based forecasts and assessed high, base, and low case scenarios.
- Conducted a GAC & Client Strategy Workshop to present the results of research and models supported. Facilitated a full day session, working through three different potential investment scenarios to align the team and make one selection. Documented the results of the four phases in two summary presentations – one for investors and the second for internal communication with management and employees.
Deliverables & Outcome:
- Overall 5 year Corporate Strategic Plan – Vision, Key Objectives, Goals, Milestones, Metrics, etc. Biotech Market Outlook across target disease areas. Participation and differentiation requirements.
- Portfolio assessment, scenario development, economic model of scenarios, portfolio optimization analysis and strategy.
- R&D investment prioritization, timing, resources, and preliminary commercialization strategy.
- Executive Team Strategy alignment through GAC’s process and facilitation.
- Detailed document of each project phase, and summary document shared with Board of Directors.
Leading Molecular Diagnostic Company
Portfolio Strategic Planning
CEO, Chairman of the Board, CFO, R&D VP, & Marketing VP
Can You Relate?
Every business is unique, but your company may be facing many of the same challenges as the clients described in these case studies.
Please contact us to discuss how we can help you.